Affinity Asset Advisors, LLC - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 106 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Affinity Asset Advisors, LLC ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q1 2023$1,087,490
-50.8%
149,586
-50.7%
0.36%
-58.6%
Q4 2022$2,210,459
-61.7%
303,218
-59.4%
0.87%
-46.2%
Q3 2022$5,771,000
+3216.7%
746,576
+2818.8%
1.61%
+2106.8%
Q2 2022$174,00025,5780.07%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q3 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders